AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Amoéba

AGM Information Jun 12, 2017

1107_agm-r_2017-06-12_ce27ad6a-9a7b-49db-b6c2-736845542b6d.pdf

AGM Information

Open in Viewer

Opens in native device viewer

PRESS RELEASE

Chassieu, 12th June 2017

ORDINARY AND EXTRAORDINARY ANNUAL GENERAL MEETING TO BE HELD ON 22ND JUNE 2017

MODALITIES THROUGH WHICH THE PREPARATORY DOCUMENTS WILL BE MADE AVAILABLE

The company's shareholders are invited to attend the ordinary and extraordinary annual general meetings which will be held at:

10 am, Thursday 22nd June

in the Hotel Kyriad Prestige Lyon Saint-Priest Eurexpo, Parc Technoland ZI Champ Dolin, 9 Rue Aimé Cotton - 69800 Saint-Priest

The notice of the meeting, including the agenda and the planned resolutions, was published in the BALO (Bulletin of obligatory legal announcements) of 17th May 2017; the notice convening the meeting was published in the BALO of 7th June 2017.

The documents stipulated by article R.225-83 of the French commercial code are available to shareholders from the moment that the assembly is convened, in line with the applicable regulatory requirements:

  • Any named shareholder can, until the fifth day (inclusive) before the assembly, ask the company to send them these documents. For holders of bearer shares, this right can only be exercised upon presentation of a statement of participation in the accounts of bearer shares held by the authorised intermediary;
  • Any shareholder can consult these documents at the company's headquarters during the 15 days preceding the date of the assembly.

About AMOEBA:

AMOEBA develops a biological biocide BIOMEBA capable of eliminating waterborne bacterial risk. This solution is an alternative to chemicals traditionally used in the cooling water treatment sector. In a worldwide market for chemical biocides estimated to be worth EUR 21 bn(1), AMOEBA is today focusing on the cooling tower application estimated to be worth EUR 1.7 bn(2). BIOMEBA has not yet been granted marketing authorization in the USA, Europe and Canada. AMOEBA is taking the required regulatory steps

to obtain marketing authorizations in those territories for the use of BIOMEBA in cooling water systems. Based in Chassieu (Lyon, France), AMOEBA is quoted on compartment C of the Euronext Paris stock exchange and joined the CAC® Small index on 21st September 2015. For more information: www.amoeba-biocide.com.

(1): Sources combined by Amoeba from water treatment agencies, Freedonia, Eurostat and MarketsandMarkets (2): Amoeba data combined from the following sources: DRIRE 2013, Eurostat, ARHIA 2013

Contacts:

Amoéba Nathalie COMBROUSSE Marketing Communication Manager Tel. : +33 (0)4 81 09 18 15 [email protected]

Actifin Ghislaine GASPARETTO Financial communication +33(0)1 5688 1111 [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.